Dunedin, New Zealand

Philip Myers Heyward

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Otago Innovation Limited. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip Myers Heyward. Retrieved from https://idiyas.com/inventor/philip-myers-heyward

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Philip Myers Heyward

Introduction

Philip Myers Heyward is a notable inventor based in Dunedin, New Zealand. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes and related disorders. His work focuses on innovative combinations of flavonoids that have the potential to improve health outcomes for individuals suffering from these conditions.

Latest Patents

Philip Myers Heyward holds 1 patent for his invention titled "Pharmaceutical combinations and methods for the treatment of diabetes and associated disorders." This patent describes pharmaceutical compositions that comprise combinations of flavonoids, which may be utilized to treat and/or prevent diabetes and its associated diseases, conditions, and disorders. The invention also outlines methods for treating diabetes using these pharmaceutical compositions.

Career Highlights

Heyward is associated with Otago Innovation Limited, where he continues to develop and refine his innovative ideas. His work has the potential to make a significant impact on the treatment of diabetes, a condition that affects millions of people worldwide. His dedication to research and development in this area showcases his commitment to improving public health.

Collaborations

Heyward collaborates with Alexander Tups, a fellow innovator in the field. Their partnership exemplifies the importance of teamwork in advancing scientific research and developing effective solutions for health-related challenges.

Conclusion

Philip Myers Heyward's contributions to pharmaceutical innovations highlight the potential of flavonoid combinations in treating diabetes and associated disorders. His work at Otago Innovation Limited and collaboration with Alexander Tups underscore the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…